With a market projected to reach US$ 2,301.6 billion by 2032, the pharmaceutical manufacturing industry is not just growing—it’s evolving. The convergence of digital innovation, changing disease ...
Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...
Successful collaborations are built on open communication and a shared commitment to both risks and rewards. These ...
The IQVIA Institute for Human Data Science has released, Global Trends in R&D 2025 report, Progress in Recapturing Momentum ...
The recent reductions in the US Food and Drug Administration’s workforce are poised to have a substantial impact on drug and biologic ...